Elderdery, A.Y.; Tebein, E.M.; Alenazy, F.O.; Elkhalifa, A.M.E.; Shalabi, M.G.; Abbas, A.M.; Alhassan, H.H.; Davuljigari, C.B.; Mills, J.
Impact of Methionine Synthase Reductase Polymorphisms in Chronic Myeloid Leukemia Patients. Genes 2022, 13, 1729.
https://doi.org/10.3390/genes13101729
AMA Style
Elderdery AY, Tebein EM, Alenazy FO, Elkhalifa AME, Shalabi MG, Abbas AM, Alhassan HH, Davuljigari CB, Mills J.
Impact of Methionine Synthase Reductase Polymorphisms in Chronic Myeloid Leukemia Patients. Genes. 2022; 13(10):1729.
https://doi.org/10.3390/genes13101729
Chicago/Turabian Style
Elderdery, Abozer Y., Entesar M. Tebein, Fawaz O. Alenazy, Ahmed M. E. Elkhalifa, Manar G. Shalabi, Anass M. Abbas, Hassan H. Alhassan, Chand B. Davuljigari, and Jeremy Mills.
2022. "Impact of Methionine Synthase Reductase Polymorphisms in Chronic Myeloid Leukemia Patients" Genes 13, no. 10: 1729.
https://doi.org/10.3390/genes13101729
APA Style
Elderdery, A. Y., Tebein, E. M., Alenazy, F. O., Elkhalifa, A. M. E., Shalabi, M. G., Abbas, A. M., Alhassan, H. H., Davuljigari, C. B., & Mills, J.
(2022). Impact of Methionine Synthase Reductase Polymorphisms in Chronic Myeloid Leukemia Patients. Genes, 13(10), 1729.
https://doi.org/10.3390/genes13101729